Join Lachman Consultants (Ireland) in Leipzig, Germany for the 2023 Parenteral Drug Association (PDA) Good Aseptic Manufacturing Conference on May 23 – 24, to discuss the implications of the new GMP Annex 1 and share insights to help you prepare. As a Gold Sponsor at this year’s event, Lachman will be represented by: John Darby, […]
Join Lachman Consultants at this year’s FDLI Annual Conference in Washington, DC, May 17 –18, 2023, for a two-day hybrid event that will address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. Lachman Consultants will be represented by: Martin Shimer (Executive Director) Rachel Thompson, JD (Senior Director) David Petshaft, […]
Lachman Consultant Services, Inc. (Lachman Consultants), recently completed the expansion of our existing operations in Ireland to support the growing demand for services in the European region. Operating under the name Lachman Consultants (Ireland) Limited, this expanded pharmaceutical quality and regulatory consultancy is the most recent development in our global expansion to better serve the […]
On Tuesday December 13, Lachman President and CEO, Fran Zipp will be participating on a panel in a live webinar on “Excelling in a Multigenerational Workplace” as part of the DCAT Alliance for Industry Women Committee. This issue is one that transcends the pharmaceutical industry and is certainly not experienced exclusively by females. The varying […]
For the past 18 years, the Scrip Awards has been taking place in London where over 400 industry leaders gather to celebrate and recognize the best innovations and achievements in the global biopharmaceutical industry. This year, Lachman CEO and President Frances Zipp and John Darby, Senior Director will be attending to celebrate the winners across […]
On Tuesday, November 8, 2022, as part of the GRx+Biosims conference being held by the Association for Accessible Medicines, Marty Shimer will be participating on a panel in the Science and Regulatory Learning Track on pH Adjusters and Q1/Q2 Assessments. This session will explore FDA’s plans for pH adjusters and Q1/Q2 assessments and provide industry […]
Anyone who has been involved in basic science knows that the ultimate goal is publication of your research in a peer reviewed journal. If you work in discovery in a firm, the goal is the same, and the company looks to commercialize promising leads as potential therapeutics. We are happy to announce that one of […]
(Westbury, NY – July 11, 2022) – Frances Zipp, President and CEO of Lachman Consultant Services, Inc. (Lachman Consultants), a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, announced today that CAPT Martin H. Shimer, II joined the firm as Executive Director, Regulatory, effective July 11, 2022. In this […]
On Thursday, June 30th, at the Annual Conference of Medicines for Europe, Frances Zipp, President and CEO of Lachman Consultant Services, Inc., will be addressing the audience as a part of the Keynote Speech at the Dolce Sitges Hotel in Barcelona, Spain. Fran will be addressing humanitarian efforts by industry to provide patients in war-torn […]
(Westbury, NY – March 16, 2021) Fran Zipp, President and CEO of Lachman Consultants, Inc., a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, today announced that John McShane has joined the firm as Vice President of Cell & Gene Therapy, Compliance and Business Development. In this role, McShane […]
